97 related articles for article (PubMed ID: 29953851)
1. TAZ
Yao CB; Zhang M; Zhou X; Lei QY; Yin M
Biochem Biophys Res Commun; 2018 Sep; 503(4):2240-2247. PubMed ID: 29953851
[TBL] [Abstract][Full Text] [Related]
2. Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression.
Xie D; Cui J; Xia T; Jia Z; Wang L; Wei W; Zhu A; Gao Y; Xie K; Quan M
Oncotarget; 2015 Nov; 6(34):35949-63. PubMed ID: 26416426
[TBL] [Abstract][Full Text] [Related]
3. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer.
Li Z; Wang Y; Zhu Y; Yuan C; Wang D; Zhang W; Qi B; Qiu J; Song X; Ye J; Wu H; Jiang H; Liu L; Zhang Y; Song LN; Yang J; Cheng J
Mol Oncol; 2015 Jun; 9(6):1091-105. PubMed ID: 25704916
[TBL] [Abstract][Full Text] [Related]
4. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.
Valencia-Sama I; Zhao Y; Lai D; Janse van Rensburg HJ; Hao Y; Yang X
J Biol Chem; 2015 Jul; 290(27):16906-17. PubMed ID: 25995450
[TBL] [Abstract][Full Text] [Related]
5. The Hippo Signaling Pathway in Pancreatic Cancer.
Ansari D; Ohlsson H; Althini C; Bauden M; Zhou Q; Hu D; Andersson R
Anticancer Res; 2019 Jul; 39(7):3317-3321. PubMed ID: 31262852
[TBL] [Abstract][Full Text] [Related]
6. The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase.
Liu CY; Zha ZY; Zhou X; Zhang H; Huang W; Zhao D; Li T; Chan SW; Lim CJ; Hong W; Zhao S; Xiong Y; Lei QY; Guan KL
J Biol Chem; 2010 Nov; 285(48):37159-69. PubMed ID: 20858893
[TBL] [Abstract][Full Text] [Related]
7. PARD3 induces TAZ activation and cell growth by promoting LATS1 and PP1 interaction.
Lv XB; Liu CY; Wang Z; Sun YP; Xiong Y; Lei QY; Guan KL
EMBO Rep; 2015 Aug; 16(8):975-85. PubMed ID: 26116754
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase 5/protein kinase G signal governs stemness of prostate cancer stem cells through Hippo pathway.
Liu N; Mei L; Fan X; Tang C; Ji X; Hu X; Shi W; Qian Y; Hussain M; Wu J; Wang C; Lin S; Wu X
Cancer Lett; 2016 Aug; 378(1):38-50. PubMed ID: 27179930
[TBL] [Abstract][Full Text] [Related]
9. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway.
Lei QY; Zhang H; Zhao B; Zha ZY; Bai F; Pei XH; Zhao S; Xiong Y; Guan KL
Mol Cell Biol; 2008 Apr; 28(7):2426-36. PubMed ID: 18227151
[TBL] [Abstract][Full Text] [Related]
10. A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer.
Romero-Pérez L; Garcia-Sanz P; Mota A; Leskelä S; Hergueta-Redondo M; Díaz-Martín J; López-García MA; Castilla MA; Martínez-Ramírez A; Soslow RA; Matias-Guiu X; Moreno-Bueno G; Palacios J
Mod Pathol; 2015 Nov; 28(11):1492-503. PubMed ID: 26381823
[TBL] [Abstract][Full Text] [Related]
11. Validation of chemical compound library screening for transcriptional co-activator with PDZ-binding motif inhibitors using GFP-fused transcriptional co-activator with PDZ-binding motif.
Nagashima S; Maruyama J; Kawano S; Iwasa H; Nakagawa K; Ishigami-Yuasa M; Kagechika H; Nishina H; Hata Y
Cancer Sci; 2016 Jun; 107(6):791-802. PubMed ID: 27009852
[TBL] [Abstract][Full Text] [Related]
12. TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma.
Xiao H; Jiang N; Zhou B; Liu Q; Du C
Cancer Sci; 2015 Feb; 106(2):151-9. PubMed ID: 25495189
[TBL] [Abstract][Full Text] [Related]
13. Hippo pathway - brief overview of its relevance in cancer.
Zygulska AL; Krzemieniecki K; Pierzchalski P
J Physiol Pharmacol; 2017 Jun; 68(3):311-335. PubMed ID: 28820389
[TBL] [Abstract][Full Text] [Related]
14. The Hippo pathway regulates Wnt/beta-catenin signaling.
Varelas X; Miller BW; Sopko R; Song S; Gregorieff A; Fellouse FA; Sakuma R; Pawson T; Hunziker W; McNeill H; Wrana JL; Attisano L
Dev Cell; 2010 Apr; 18(4):579-91. PubMed ID: 20412773
[TBL] [Abstract][Full Text] [Related]
15. The Hippo-YAP pathway: new connections between regulation of organ size and cancer.
Zhao B; Lei QY; Guan KL
Curr Opin Cell Biol; 2008 Dec; 20(6):638-46. PubMed ID: 18955139
[TBL] [Abstract][Full Text] [Related]
16. MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity.
Santoro R; Zanotto M; Carbone C; Piro G; Tortora G; Melisi D
Anticancer Res; 2018 Apr; 38(4):1937-1946. PubMed ID: 29599309
[TBL] [Abstract][Full Text] [Related]
17. AMOTL2 interaction with TAZ causes the inhibition of surfactant proteins expression in lung cells.
Lucci V; Di Palma T; D'Ambrosio C; Scaloni A; Zannini M
Gene; 2013 Oct; 529(2):300-6. PubMed ID: 23911299
[TBL] [Abstract][Full Text] [Related]
18. SnoN Antagonizes the Hippo Kinase Complex to Promote TAZ Signaling during Breast Carcinogenesis.
Zhu Q; Le Scolan E; Jahchan N; Ji X; Xu A; Luo K
Dev Cell; 2016 Jun; 37(5):399-412. PubMed ID: 27237790
[TBL] [Abstract][Full Text] [Related]
19. Biophysical studies and modelling indicate the binding preference of TAZ WW domain for LATS1 PPxY motif.
Verma A; Lin F; Tan YC; Hidayat MN; Jobichen C; Fan H; Sivaraman J
Biochem Biophys Res Commun; 2018 Jul; 502(3):307-312. PubMed ID: 29787761
[TBL] [Abstract][Full Text] [Related]
20. Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis.
Li YW; Shen H; Frangou C; Yang N; Guo J; Xu B; Bshara W; Shepherd L; Zhu Q; Wang J; Hu Q; Liu S; Morrison CD; Sun P; Zhang J
Cell Cycle; 2015; 14(1):146-56. PubMed ID: 25602524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]